Orbimed Advisors - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 149 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q2 2021$28,713,000
-42.4%
848,503
-29.7%
0.29%
-37.8%
Q1 2021$49,844,000
-10.2%
1,206,886
-5.7%
0.47%
-4.1%
Q4 2020$55,530,000
+109.3%
1,280,086
+106.9%
0.49%
+45.5%
Q3 2020$26,537,000
+137.4%
618,586
+158.6%
0.33%
+112.7%
Q2 2020$11,180,000239,1860.16%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2023
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
Green Alpha Advisors, LLC 21,538$550,2960.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders